Replies to post #11861 on Todos Med Ltd (TOMDF)

[redspeed]

I guess we all would love to see Todos organically increase 100x and go from $0.02 to $2.00 which would take a $2B market cap. I believe the cards are lined up to potentially get there one day, maybe in the next year, depending on how the Dx and Tollovid/r pan out.

But to get to the NASDAQ within say the next 3-4 months, a RS would be in order. RS do work when a company actually has great products, growing revenue, etc. and does it to Uplist

RS don't work when a company does it to stay listed.

RS fail on uplist when a company thinks they have all their ducks in a row, including growing revenue and don't.

I believe Todos will only uplist if the catalysts pre and post uplist are there. Otherwise why wouldn't they just wait? It's going to be pretty obvious if/when they hit those milestones.

[DreyDreyDrey]

I try to see every point of view. So I read what other people write. I don’t want to be right. I want to make money.

So I play through the merit scenario. If we were to wait for it to move up on it’s own merit. So let’s say the share price goes up 1% a day. For a year. That would mean stellar performance. It would still take years to be able to meet NASDAQ listing requirements. No one came here to wait years to uplist. To then wait another year or two to see a real return. 5 years to make money on a penny stock is nuts. My real money with my financial advisor was up over 400% during the pandemic. This is why he only give me a few thousand dollars a year to play with. While he makes me 300% return (and he readjusted, I may end the year up (350%). I lost 80% of equity. Professional vs retail. He isn’t reading Twitter. He is looking at solid financials vs dreams.